Apoptotic neuronal death following cerebral ischaemia

Journal of Clinical Neuroscience

Volumn 5, Issue 2, 1998, Pages 125-145

  Miles, Andrew N ^a,b   Knuckey, Neville W ^a  

^a Department of Forensic Pathology State Health Laboratories QEII Medical Center   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Apoptosis; bcl 2; Caspases; Cell cycle; Cerebral ischaemia; Heat shock proteins; Immediate early genes; Neurotrophins; TNF

Indexed keywords

EID: 0000722095     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(98)90027-3     Document Type: Review

References (286)

1. Anderson CS, Jamrozik KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG. Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke Study, 1989-1990. Med J Aust 1993; 158(2): 85-89.
2. Anderson CS, Jamrozik KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG. Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989-1990. Med J Aust 1993; 158(2): 80-84.
3. Kraus JF, McArthur DL. Epidemiologic aspects of brain injury. Neurol Clin 1996; 14(2): 435-450.
4. Sosin DM, SniezekJE, Thurman DJ. Incidence of mild and moderate brain injury in the United States, 1991. Brain Injury 1996; 10(1): 47-54.
5. Selecki BR, Ring IT, Simpson DA, Vanderfield GK, Sewell MF. Trauma to the central and peripheral nervous systems: Part I: an overview of mortality, morbidity and costs; N.S.W. 1977. Aust NZJ Surg 1982; 52(1): 93-102.
6. Hunter AJ, Green AR, Cross AJ. Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs? TIPS 1995; 16: 123-128.
7. Small DL, Buchan AM. Mechanisms of cerebral ischemia: intracellular cascades and therapeutic interventions. J Cardiothorac Vasc Anesth 1996; 10(1): 139-146.
8. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982; 239(1): 57-69.
9. Smith ML, Auer RN, Siesjo BK. The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol (Berl) 1984; 64: 319-332.
10. Pulsinelli WA, BrierleyJB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982; 11: 491-498.
11. Macrae IM. New models of focal cerebral ischaemia. Br J Clin Pharmac 1992; 34: 302-308.
12. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 1992; 77: 169-184.
13. McAuley MA. Rodent models of focal ischemia. Cerebrovasc Brain Metab Rev 1995; 7(2): 153-180.
14. Chopp M, Li Y. Apoptosis in focal cerebral ischemia. Acta Neurochir Suppl (Wien) 1996; 66: 21-26.
15. Li Y, Chopp M, Jiang N, Yao F, Zaloga C. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1995; 15(3): 389-397.
16. Cummings JL, Tomiyasu U, Read S, Benson DF. Amnesia with hippocampal lesions after cardiopulmonary arrest. Neurology 1984; 34(5): 679-681.
17. Petito CK, Feldmann E, Pulsinelli WA, Plum F. Delayed hippocampal damage in humans following cardio-respiratory arrest. Neurology 1987; 37(8): 1281-1286.
18. Kotapka MJ, Graham DI, Adams JH, Gennarelli TA. Hippocampal pathology in fatal non-missile human head injury. Acta Neuropathol (Berl) 1992; 83(5): 530-534.
19. Kotapka MJ, Graham DI, Adams JH, Gennarelli TA. Hippocampal pathology in fatal human head injury without high intracranial pressure. J Neurotrauma 1994; 11 (3): 317-324.
20. Zola-Morgan S, Squire LR, Rempel NL, Clower RP, Amaral DG. Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J Neurosci 1992; 12(7): 2582-2596.
21. Auer RN, Jensen ML, Whishaw IQ. Neurobehavioural deficit due to ischemic brain damage limited to half of the CA1 sector of the hippocampus. J Neurosci 1989; 9(5): 1641-1647.
22. Volpe BT, Hirst W. The characterisation of an amnesic syndrome following hypoxic ischemic injury. Arch Neurol 1983; 40: 436-440.
23. Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medial temporal region: Enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986; 6: 2950-2967.
24. Hakim AM, Evans AC, Berger L. The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J Cereb Blood Flow Metab 1989; 9: S23-34.
25. Linnik MD. Role of apoptosis in acute neurodegenerative disorders. Restorative Neurology and Neuroscience 1996; 9: 219-225.
26. Bredesen DE. Neural apoptosis. Ann Neurol 1995; 38: 839-851.
27. Nicholson DW. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nature Biotechnology 1996; 14: 297-301.
28. Johnson EM, JR, Greenlund LJ, Akins PT, Hsu CY. Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury. J Neurotrauma 1995; 12(5): 843-852.
29. Schwartz LM, Milligan CE. Cold thoughts of death: the role of ICE proteases in neuronal cell death. Trends Neurosci 1996; 19(12): 555-562.
30. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
31. Fadok VA, Voelker DR, Campbell PA et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-2216.
32. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-556.
33. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
34. Li Y, Chopp M Jiang N, Zhang ZG, Zaloga C. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke 1995; 26(7): 1252-1257; discussion 1257-1258.
35. Nitatori T, Sato N, Waguri S et al. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurol Sci 1995; 15(2): 1001-1011.
36. Charriaut-Marlangue C, Aggoun-Zouaoui D, Represa A, Ben-Ari Y. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity. Trends Neurosci 1996; 19: 109-114.
37. MacManus JP, Buchan AM, Hill IE, Rasquinha I, Preston E. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci Lett 1993; 164 (1-2): 89-92.
38. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 1993; 24: 2002-2009.
39. Li Y, Chopp M, Jiang N, Zaloga C. In situ detection of DNA fragmentation after focal cerebral ischemia in mice. Brain Res Mol Brain Res 1995; 28(1): 164-168.
40. Li Y, Sharov VG, Jiang N, Zaloga C, Sabbah HN, Chopp M. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am J Pathol 1995; 146(5): 1045-1051.
41. Siesjo BK, Katsura K, Zhao Q et al. Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J Neurotrauma 1995; 12(5): 943-956.
42. Siesjo BK. Basic mechanisms of traumatic brain damage. Ann Emerg Med 1993; 22(6): 959-969.
43. Sims NR, Zaidan E. Biochemical changes associated with selective neuronal death following short-term cerebral ischaemia. IntJ Biochem Cell Biol 1995; 27(6): 531-550.
44. Choi DW. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 1995; 18(2): 58-60.
45. Choi DW. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci 1988; 11: 465-469.
46. Tymianski M, Tator CH. Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 1996; 38: 1176-1195.
47. Siesjo BK. Calcium-mediated processes in neuronal degeneration. Ann N Y Acad Sci 1994; 747: 140-161.
48. Szatkowski M, Attwell D. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci 1994; 17(9): 359-365.
49. Meldrum BS. Excitatory amino acid receptors and their role in epilepsy and cerebral ischemia. Ann NY Acad Sci 1995; 757: 492-505.
50. Martin RL. Experimental neuronal protection in cerebral ischaemia. Part 1: Experimental models and pathophysiological responses. J Clin Neurosci 1997; 4(2): 96-113.
51. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336(6197): 385-388.
52. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997; 20: 132-139.
53. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682-685.
54. Bredt DS, Hwang PM, Snyder SH. Localisation of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768-770.
55. Katsura K, Rodriguez de Turco EB, Folbergrova J, Bazan NG, Siesjo BK. Coupling among energy failure, loss of ion homeostasis, and phospholipase A2 and C activation during ischemia. J Neurochem 1993; 61(5): 1677-1684.
56. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J Neurosurg 1992; 77: 337-354.
57. Miller B, Sarantis M, Traynelis SF, Attwell D. Potentiation of NMDA receptor currents by arachidonic acid. Nature 1992; 355 (6362): 722-725.
58. White BC, Grossman LI, Krause GS. Brain injury by global ischemia and reperfusion: A theoretical perspective on membrane damage and repair. Neurology 1993; 43: 1656-1665.
59. Dietrich WD. Morphological manifestations of reperfusion injury in brain. Ann NY Acad Sci 1994; 723: 15-24.
60. Traystman RJ, Kirsch JR, Koehler RC. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 1991; 71(4): 1185-1195.
61. Kirsch JR, Helfaer MA, Lange DG, Traystman RJ. Evidence for free radical mechanisms of brain injury resulting from ischemia/reperfusion-induced events. J Neurotrauma 1992; 9 Suppl 1: S157-63.
62. Kukreja RC, Kontos HA, Hess ML, Ellis EF. PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res 1986; 59: 612-619.
63. Chan PH. Role of oxidants in ischemic brain damage. Stroke 1996; 27(6): 1124-1129.
64. GutteridgeJM. Hydroxyl radicals, iron, oxidative stress, and neurodegeneration. Ann NY Acad Sci 1994; 738: 201-213.
65. Piantadosi CA, Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 1996; 27(2): 327-331; discussion 332.
66. Krause GS, Tiffany BR. Suppression of protein synthesis in the reperfused brain. Stroke 1993; 24(5): 747-755; discussion 755-756.
67. Araki T, Kato H, Inoue T, Kogure K. Regional impairment of protein synthesis following brief cerebral ischemia in the gerbil. Acta Neuropathol (Berl) 1990; 79: 501-505.
68. Bodsch W, Takahashi K, Barbier A, Ophoff BG, Hossmann KA. Cerebral protein synthesis and ischemia. Prog Brain Res 1985; 63: 197-210.
69. Hossmann KA. Disturbances of cerebral protein synthesis and ischemic cell death. Prog Brain Res 1993; 96: 161-177.
70. Cooper HK, Zalewska T, Kawakami S, Hossmann KA, Kleihues P. The effect of ischaemia and recirculation on protein synthesis in the rat brain. J Neurochem 1977; 28(5): 929-934.
71. Hu BR, Wieloch T. Stress-induced inhibition of protein synthesis initiation: modulation of initiation factor 2 and guanine nucleotide exchange factor activities following transient cerebral ischemia in the rat. J Neurosci 1993; 13(5): 1830-1838.
72. BurdaJ, Martin E, Garcia A, Alcazar A, Fando JL, Salinas M. Phosphorylation of the α subunit of initiation factor 2 correlates with the inhibition of translation following transient cerebral ischemia in the rat. Biochem J 1994; 302: 335-338.
73. Siesjo BK, Bengtsson F. Calcium fluxes, calcium antagonists and calcium related pathology in brain ischemia, hypoglycemia and spreading depression. J Cereb Blood Flow Metab 1989; 9: 127-140.
74. Rotman EI, Brostrom MA, Brostrom CO. Inhibition of protein synthesis in intact mammalian cells by arachidonic acid. Biochem J 1992; 282: 487-494.
75. White BC, Grossman LI, O'Neil BJ et al. Global brain ischemia and reperfusion. Ann Emerg Med 1996; 27(5): 588-594.
76. McGowan AJ, Ruiz-Ruiz MC, Gorman AM, Lopez-Rivas A, Cotter TG. Reactive oxygen intermediate (s) (ROI): common mediator(s) of poly(ADP-ribose)polymerase (PARP) cleavage and apoptosis. FEBS Lett 1996; 392(3): 299-303.
77. 2+ and reactive oxygen species in staurosporine-induced neuronal apoptosis. J Neurochem 1997; 68(4): 1679-1685.
78. Ratan RR, Murphy TH, Baraban JM. Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 1994; 62(1): 376-379.
79. Ankarcrona M, Dypbukt JM, Bonfoco E et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995; 15(4): 961-973.
80. 2+ ionophore-induced apoptosis in cultured rat cortical neurons. Biochem Biophys Res Commun 1996; 227(2): 513-518.
81. 2+ ionophore-induced apoptosis on cultured embryonic rat cortical neurons. Brain Res 1994; 652(1): 65-70.
82. Joseph R, Li W, Han E. Neuronal death, cytoplasmic calcium and internucleosomal DNA fragmentation: evidence for DNA fragments being released from cells. Brain Res Mol Brain Res 1993; 17(1-2): 70-76.
83. Jacobson MD. Reactive oxygen species and programmed cell death. TIBS 1996; 21: 83-86.
84. Shimizu S, Eguchi Y, Kamiike W et al. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bel-XL. Cancer Res 1996; 56(9): 2161-2166.
85. Richter C, Schweizer M, Cossarizza A, Franceschi C. Control of apoptosis by the cellular ATP level. FEBS Lett 1996; 378(2): 107-110.
86. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate concentration: A switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185(8): 1481-1486.
87. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984; 226: 1097-1099.
88. Nunez G, London L, Hockenbery DM et al. Deregulated bcl-2 expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990; 144: 3602-3610.
89. Hockenbery DM. The bcl-2 oncogene and apoptosis. Semin Immunol 1992; 4(6): 413-420.
90. Krajewski S, Tanaka K, Takayama S, Schibler MJ, Fenton W, Reed JC. Investigation of the subcellular distribution of the Bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membranes. Cancer Res 1993; 53: 4701-4714.
91. White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10(1): 1-15.
92. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerisation with Bax. Nature 1994; 369: 321-323.
93. Boise LH, Gonzalez-Garcia M, Postema CE et al. bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic death. Cell 1993; 74: 597-608.
94. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerises in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
95. Chittenden T, Harrington EA, O'Connor R et al. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995; 374: 733-736.
96. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996; 88(2): 386-401.
97. Yin XM, Oltvai ZN, Veis-Novack DJ, Linette GP, Korsmeyer SJ. Bcl-2 gene family and the regulation of programmed cell death. Cold Spring Harb Symp Quant Biol 1994; 59: 387-393.
98. Korsmeyer SJ. Regulators of cell death. Trends Genet 1995; 11(3): 101-105.
99. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75(2): 241-251.
100. Korsmeyer SJ, Yin XM, Oltvai ZN, Veis-Novack DJ, Linette GP. Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim Biophys Acta 1995; 1271(1): 63-66.
101. Kane DJ, Sarafian T, Anton PA et al. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 1993; 262: 1274-1277.
102. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 1995; 374(6525): 811-813.
103. Jacobson MD, Raff MC. Programmed cell death and Bcl-2 protection in very low oxygen. Nature 1995; 374(6525): 814-816.
104. Lam M, Dubyak G, Chen L, Nunez G, Miesfeld RL, Distelhorst CW. Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc Natl Acad Sci USA 1994; 91(14): 6569-6573.
105. Hale AJ, Smith CA, Sutherland LC et al. Apoptosis: molecular regulation of cell death. EurJ Biochem 1996; 236(1): 1-26.
106. Baffy G, Miyashita T, Williamson JR, Reed JC. Apoptosis induced by withdrawal of interleukin-3 from an IL-3 dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 1993; 268: 6511-6519.
107. 2+ pool depletion. Oncogene 1996; 12(10): 2051-2055.
108. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997; 18(1): 44-51.
109. Zamzami N, Marchetti P, Castedo M et al. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 1996; 384(1): 53-57.
110. Marchetti P, Castedo M, Susin SA et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996; 184: 1155-1160.
111. Zamzami N, Marchetti P, Castedo M et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995; 181(5): 1661-1672.
112. Susin SA, Zamzami N, Castedo M et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 1996; 184(4): 1331-1341.
113. Zamzami N, Marchetti P, Castedo M et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995; 182(2): 367-377.
114. Zamzami N, Susin SA, Marchetti P et al. Mitochondrial control of nuclear apoptosis [see comments]. J Exp Med 1996; 183(4): 1533-1544.
115. Petit PX, Susin SA, Zamzami N, Mignotte B, Kroemer G. Mitochondria and programmed cell death: back to the future. FEBS Lett 1996; 396(1): 7-13.
116. Schinder AF, Olson EC, Spitzer NC, Montai M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 1996; 16(19): 6125-6133.
117. Mattson MP, Zhang Y, Bose S. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Experimental Neurology 1993; 121(1): 1-13.
118. Zhong LT, Sarafian T, Kane DJ et al. bd-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 1993; 90(10): 4533-4537.
119. Krajewski S, Mai JK, Krajewska M, Sikorska M, Mossakowski MJ, Reed JC. Upregulation of bax protein levels in neurons following cerebral ischemia. J Neurosci 1995; 15(10): 6364-6376.
120. Hara A, Iwai T, Niwa M et al. Immunohistochemical detection of Bax and Bcl-2 proteins in gerbil hippocampus following transient forebrain ischemia. Brain Res 1996; 711(1-2): 249-253.
121. Martinou JC, Dubois-Dauphin M, Staple JK et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994; 13(4): 1017-1030.
122. Linnik MD, Zahos P, Geschwind MD, Federoff HJ. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 1995; 26(9): 1670-4; discussion 1675.
123. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C. elegans. Cell 1986; 44(6): 817-829.
124. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267(5203): 1445-1449.
125. Hengartner MO, Ellis RE, Horvitz HR. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 1992; 856: 494-499.
126. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994; 76(4): 665-676.
127. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG, Dixit VM. Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem 1996; 271 (9): 4573-4576.
128. Yuan JY, Horvitz HR. The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. Dev Biol 1990; 138(1): 33-41.
129. Yuan JY, Horvitz HR. The Caenorhabditis elegens gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development 1992; 116: 309-320.
130. Golstein P. Controlling cell death. Science 1997; 275: 1081-1082.
131. Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM. Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 1997; 275: 1122-1126.
132. Wu D, Wallen HD, Nunez G. Interaction and regulation of subcellular localisation of CED-4 by CED-9. Science 1997; 25: 1126-1129.
133. Spector MS, Desnoyers S, Hoeppner DJ, Hengartner MO. Interaction between the C. elegans cell death regulators CED-9 and CED-4. Nature 1997; 385(6617): 653-656.
134. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993; 75(4): 641-652.
135. Kostura MJ, Tocci MJ, Limjuco G et al. Identification of a monocyte specific pre-interleukin 1β convertase enzyme. Proc Natl Acad Sci USA 1989; 86: 5227-5231.
136. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993; 75(4): 653-660.
137. Thornberry NA, Molineaux SM. Interleukin-1 beta converting enzyme: a novel cysteine protease required for IL-1 beta production and implicated in programmed cell death. Protein Sci 1995; 4(1): 3-12.
138. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEBJ 1996; 10(5): 587-597.
139. Alnemri ES, Livingston DJ, Nicholson DW et al. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171
140. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell 1995; 82: 349-352.
141. Kumar S, Harvey NL. Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett 1995; 375 (3): 169-173.
142. Troy CM, Stefanis L, Prochiantz A, Greene LA, Shelanski ML. The contrasting roles of ICE family proteases and interleukin-lbeta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc Natl Acad Sci USA 1996; 93(11): 5635-5640.
143. Kuida K, Lippke JA, Ku G et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995; 267(5206): 2000-2003.
144. Kuida K, Zheng TS, Na S et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368-372.
145. Xue D, Shaham S, Horvitz HR. The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Dev 1996; 10(9): 1073-1083.
146. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976-3985.
147. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994; 269: 30757-30760.
148. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995; 182(6): 1625-1634.
149. Casciola-Rosen L, Nicholson DW, Chong T et al. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death [see comments]. J Exp Med 1996; 183(5): 1957-1964.
150. Orth K, Chinnaiyan AM, Garg M, Froelich CJ, Dixit VM. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J Biol Chem 1996; 271(28): 16443-16446.
151. Takahashi A, Alnemri ES, Lazebnik YA et al. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA 1996; 93(16): 8395-8400.
152. Kayalar C, Ord T, Testa MP, Zhong LT, Bredesen DE. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci USA 1996; 93(5): 2234-2238.
153. Cryns VL, Bergeron L, Zhu H, Li H, Yuan J. Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1 beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. J Biol Chem 1996; 271(49): 31277-31282.
154. Brancolini C, Benedetti M, Schneider C. Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. EMBO J 1995; 14(21): 5179-5190.
155. Na S, Chuang TH, Cunningham A et al. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J Biol Chem 1996; 271(19): 11209-11213.
156. Wang X, Zelenski NG, YangJ, Sakai J, Brown MS, Goldstein JL. Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBOJ 1996; 15(5): 1012-1020.
157. Liu X, Kim CN, Pohl J, Wang X. Purification and characterization of an interleukin-1beta-converting enzyme family protease that activates cysteine protease P32 (CPP32).J Biol Chem 1996; 271(23): 13371-13376.
158. Srinivasula SM, Fernandes-Alnemri T, Zangrilli J et al. The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32. J Biol Chem 1996; 271 (43): 27099-27106.
159. Zhivotovsky B, Burgess DH, Orrenius S. Proteases in apoptosis. Experientia 1996; 52(10-11): 968-978.
160. Shimizu S, Eguchi Y, Kamiike W, Matsuda H, Tsujimoto Y Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 1996; 12(11): 2251-2257.
161. Monney L, Otter I, Olivier R et al. Bcl-2 overexpression blocks activation of the death protease CPP32/Yama/apopain. Biochem Biophys Res Commun 1996; 221 (2): 340-345.
162. YangJ, Xuesong L, Bhalla K et al. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-1132.
163. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; (275): 1132-1136.
164. Susin SA, Zamzami N, Castedo M et al. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J Exp Med 1997; 186(1): 25-37.
165. Srinivasan A, Foster LM, Testa MP et al. Bcl-2 expression in neural cells blocks activation of ICE/CED-3 family proteases during apoptosis. J Neurosci 1996; 16(18): 5654-5660.
166. Gagliardini V, Fernandez PA, Lee RK et al. Prevention of vertebrate neuronal death by the crmA gene [see comments] [published erratum appears in Science 1994 Jun 3; 264(5164): 1388]. Science 1994; 263(5148): 826-828.
167. Milligan CE, Prevette D, Yaginuma H et al. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 1995; 15(2): 385-393.
168. Hara H, Friedlander RM, Gagliardini V et al. Inhibition of interleukin Iβ converting enzyme family proteases reduces ischemic and excititoxic neuronal damage. Proc Natl Acad Sci U S A 1997; 94: 2007-2012.
169. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats [see comments]. Stroke 1995; 26(4): 676-680; discussion 681.
170. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 76(6): 959-962.
171. Ware CF, VanArsdale S, VanArsdale TL. Apoptosis mediated by the TNF-related cytokine and receptor families. J Cell Biochem 1996; 60(1): 47-55.
172. Itoh N, Nagata S. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J Biol Chem 1993; 268: 10932-10937.
173. Tartaglia LA, Ayers TM, Wong GHW, Goeddel DV. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993; 74: 845-853.
174. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995; 270: 7795-7798.
175. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505-512.
176. Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85(6): 817-827.
177. Boldin MP, Goncharov TM, Goltsev W, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996; 85(6): 803-815.
178. Fernandes-Alnemri T, Armstrong RC, Krebs J et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 1996; 93(15): 7464-7469.
179. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 1996; 93(25): 14486-14491.
180. Los M, Van de Craen M, Penning LC et al. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 1995; 375(6526): 81-83.
181. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995; 375 (6526): 78-81.
182. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996; 380(6576): 723-726.
183. Schlegel J, Peters I, Orrenius S et al. CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem 1996; 271(4): 1841-1844.
184. Miura M, Friedlander RM, Yuan J. Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci USA 1995; 92(18): 8318-8322.
185. Wallach D. Placing death under control. Nature 1997; 388: 123-126.
186. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kβ activation. Cell 1995; 81: 495-504.
187. Hsu H, Shu H, Baichwal V, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transcription pathways. Cell 1996; 84: 299-308.
188. Chinnaiyan AM, Tepper CG, Seldin MF et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor induced apoptosis. J Biol Chem 1996; 271(9): 4961-4965.
189. Hsu H, Huang J, Shu H, Baichwal V, Goeddel DV. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996; 4: 387-396.
190. Grimm S, Stanger BZ, Leder P. RIP and FADD: two "death domain"-containing proteins can induce apoptosis by convergent, but dissociable, pathways. Proc Natl Acad Sci USA 1996; 93(20): 10923-10927.
191. Duan H, Dixit VM. RAIDD, a novel death adaptor molecule. Nature 1997; 385: 86-89.
192. Rothwell NJ, Luheshi G. Brain TNF: Damage limitation or damaged reputation. Nature Medicine 1996; 2(7): 746-747.
193. Wallach D. Cell death induction by TNF: a matter of self control. TIBS 1997; 22: 107-109.
194. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10: 405-455.
195. Beg AA, Baltimore D. An essential role for NF-kβ in preventing TNF-α-induced cell death. Science 1996; 274: 782-784.
196. Roy N, Mahadevan MS, McLean M et al. The gene for neuronal apoptosis
197. Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA 1996; 93(10): 4974-4978.
198. Matsuyama T, Hata R, Tagaya M et al. Fas antigen mRNA induction in postischemic murine brain. Brain Res 1994; 657 (1-2): 342-346.
199. Matsuyama T, Hata R, Yamamoto Y, et al. Localization of Fas antigen mRNA induced in postischemic murine forebrain by in situ hybridization. Brain Res Mol Brain Res 1995; 34(1): 166-172.
200. Saito K, Suyama K, Nishida K, Sci Y, Basile AS. Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett 1996; 206(2-3): 149-152.
201. Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIntosh TK. Experimental brain injury induces differential expression of tumour necrosis factor-α mRNA in the CNS. Brain Res Mol Brain Res 1996; 36: 287-291.
202. Liu T, Clark RK, McDonnell PC et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994; 25 (7): 1481-1488.
203. Wang X, Yue TL, Barone FC, White RF, Gagnon RC, Feuerstein GZ. Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol 1994; 23(2-3): 103-114.
204. Buttini M, Appel K, Sauter A, Gebicke-Haerter PJ, Boddeke HW. Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience 1996; 71(1): 1-16.
205. Chao CC, Hu S. Tumour necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci 1994; 16: 172-179.
206. Cheng B, Christakos S, Mattson MP. Tumour necrosis factors protect neurons against excitotoxic/metabolic insults and promote maintenance of calcium homeostasis. Neuron 1994; 1994: 139-153.
207. Bruce AJ, Boling W, Kindy MS, et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996; 2(7): 788-794.
208. Wong GH. Protective roles of cytokines against radiation: Induction of mitochondrial MnSOD. Biochim Biophys Acta 1995; 1271: 205-209.
209. Nawashiro H, Martin D, Hallenbeck JM. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab 1997; 17(2): 229-232.
210. NTR decide? Neuron 1997; 18: 187-190.
211. Barde YA. Neurotrophins: a family of proteins supporting the survival of neurons. Prog Clin Biol Res 1994; 390: 45-56.
212. Frade JM, Rodriguez-Tebar A, Barde YA. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996; 383(6596): 166-168.
213. Rich KM. Neuronal death after trophic factor deprivation. J Neurotrauma 1992; 9 Suppl 1: S61-9.
214. Oppenheim RW. Cell death during development of the nervous system. Annu Rev Neurosci 1991; 14: 453-501.
215. Barbacid M. Structural and functional properties of the TRK family of neurotrophin receptors. Ann N Y Acad Sci 1995; 766: 442-458.
216. Kaplan DR, Miller FD. Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 1997; 9(2): 213-221.
217. Heumann R. Neurotrophin signalling. Curr Opin Neurobiol 1994; 4(5): 668-679.
218. Jelsma TN, Aguayo AJ. Trophic factors. Curr Biol 1994; 4: 717-725.
219. Parada LF, Tsoulfas P, Tessarollo L, BlairJ, Reid S, Soppet D. The Trk family of tyrosine kinases: receptors for NGF-related neurotrophins. Cold Spring Harb Symp Quant Biol 1992; 57: 43-51.
220. Ip NY, Yancopoulos GD. Neurotrophic factors and their receptors. Ann Neurol 1994; 35 Suppl: S13-6.
221. Ohmichi M, Decker SJ, Pang L, Saltiel AR. Nerve growth factor binds to the 140 kd trk proto-oncogene product and stimulates its association with the src homology domain of phospholipase C gamma 1. Biochem Biophys Res Commun 1991; 179(1): 217-223.
222. Saltiel AR, Decker SJ. Cellular mechanisms of signal transduction for neurotrophins. Bioessays 1994; 16(6): 405-411.
223. van der Geer P, Wiley S, Lai VK et al. A conserved aminoterminal She domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. Curr Biol 1995; 5(4): 404-412.
224. Baxter RM, Cohen P, Obermeier A, Ullrich A, Downes CP, Doza YN. Phosphotyrosine residues in the nervegrowth-factor receptor (Trk-A). Their role in the activation of inositolphospholipid metabolism and protein kinase cascades in phaeochromocytoma (PC12) cells. Eur J Biochem 1995; 234(1): 84-91.
225. Middlemas DS, Meisenhelder J, Hunter T. Identification of TrkB autophosphorylation sites and evidence that phospholipase C-gamma 1 is a substrate of the TrkB receptor. J Biol Chem 1994; 269(7): 5458-5466.
226. Zirrgiebel U, Ohga Y, Carter B et al. Characterization of TrkB receptor-mediated signaling pathways in rat cerebellar granule neurons: involvement of protein kinase C in neuronal survival. J Neurochem 1995; 65(5): 2241-2250.
227. Lindvall O, Kokaia Z, Bengzon J, Elmer E, Kokaia M. Neurotrophins and brain insults. Trends Neurosci 1994; 17(11): 490-496.
228. Takeda A, Onodera H, Sugimoto A, Kogure K, Obinata M, Shibahara S. Coordinated expression of messenger RNAs for nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in the rat hippocampus following transient forebrain ischemia. Neuroscience 1993; 55(1): 23-31.
229. Kokaia Z, Nawa H, Uchino H et al. Regional brain-derived neurotrophic factor mRNA and protein levels following transient forebrain ischemia in the rat. Brain Res Mol Brain Res 1996; 38(1): 139-144.
230. Lindvall O, Ernfors P, Bengzon J, et al. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci USA 1992; 89(2): 648-652.
231. Yamada K, Kinoshita A, Kohmura E, et al. Detection and partial purification of ischaemia-related neurotrophic activity in the periinfarcted brain tissue. Neurol Res 1992; 14(3): 267-272.
232. Lee TH, Kato H, Kogure K, Itoyama Y Temporal profile of nerve growth factor-like immunoreactivity after transient focal cerebral ischemia in rats. Brain Res 1996; 713(1-2): 199-210.
233. Deckwerth TL, Johnson EM, Jr. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol 1993; 123: 1207-1222.
234. Cheng B, Mattson MP. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 1991; 7(6): 1031-1041.
235. Shigeno T, Mima T, Takakura K, et al. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J Neurosci 1991; 11(9): 2914-2919.
236. Tanaka K, Tsukahara T, Hashimoto N, et al. Effect of nerve growth factor on delayed neuronal death after cerebral ischaemia. Acta Neurochir (Wien) 1994; 129 (1-2): 64-71.
237. Beck T, Lindholm D, Castren E, Wree A. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J Cereb Blood Flow Metab 1994; 14(4): 689-692.
238. Sinson G, Perri BR, Trojanowski JQ, Flamm ES, McIntosh TK. Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death following neurotrophin infusion after experimental traumatic brain injury. J Neurosurg 1997; 86: 511-518.
239. King KL, Cidlowski JA. Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem 1995; 58(2): 175-180.
240. Ross ME. Cell division and the nervous system: regulating the cycle from neural differentiation to death. Trends Neurosci 1996; 19(2): 62-68.
241. Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B. The biochemistry of programmed cell death. FASEB J 1995; 9(13): 1277-1287.
242. Ucker DS. Death by suicide: one way to go in mammalian cellular development? New Biol 1991; 3(2): 103-109.
243. Ashkenas J, Werb Z. Proteolysis and the biochemistry of life-or-death decisions. J Exp Med 1996; 183: 1947-1951.
244. Meikrantz W, Schlegel R. Apoptosis and the cell cycle. J Cell Biochem 1995; 58(2): 160-174.
245. Yonish-Rouach E. The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis. Experientia 1996; 52(10-11): 1001-1007.
246. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-6311.
247. Freeman RS, Estus S, Johnson EM Jr. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 1994; 12: 343-355.
248. Kranenburg O, van der Eb AJ, Zantema A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBOJ 1996; 15(1): 46-54.
249. Jordan J, Galindo MF, Prehn JH, et al. p53 expression induces apoptosis in hippocampal pyramidal neuron cultures. J Neurosci 1997; 17(4): 1397-1405.
250. Wood KA, Youle RJ. The role of free radicals and p53 in neuron apoptosis in vivo. J Neurosci 1995; 15(8): 5851-5857.
251. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M. p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol Cell Biol 1996; 16(9): 5178-5185.
252. Enokido Y, Araki T, Tanaka K, Aizawa S, Hatanaka H. Involvement of p53 in DNA strand break-induced apoptosis in postmitotic CNS neurons. Eur J Neurosci 1996; 8(9): 1812-1821.
253. Slack RS, Belliveau DJ, Rosenberg M, et al. Adenovirus-mediated gene transfer of the tumor suppressor, p53, induces apoptosis in postmitotic neurons. J Cell Biol 1996; 135(4): 1085-1096.
254. Lane DP. p53, guardian of the genome. Nature 1992; 358: 15-16.
255. Li Y, Chopp M, Zhang ZG, Zaloga C, Niewenhuis L, Gautam S. p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke 1994; 25(4): 849-855; discussion 855-856.
256. Chopp M, Li Y, Zhang ZG, Freytag SO. p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem Biophys Res Commun 1992; 182(3): 1201-1207.
257. Crumrine RC, Thomas AL, Morgan PF. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood Flow Metab 1994; 14(6): 887-891.
258. Akins PT, Liu PK, Hsu CY. Immediate early gene expression in response to cerebral ischemia. Friend or foe? Stroke 1996; 27(9): 1682-1687.
259. Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible protooncogenes fos and jun. Annu Rev Neurosci 1991; 14: 421-451.
260. Hardingham GE, Chawla S, Johnson CM, Bading H. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 1997; 385: 260-265.
261. Hsu CY, An G, Liu JS, Xue JJ, He W, Lin TN. Expression of immediate early gene and growth factor mRNAs in a focal cerebral ischemia model in the rat. Stroke 1993; 24(12 Suppl): I78-8.
262. Liu PK, CuiJK, He YY, Hsu CY Suppression of cerebral ischemia induced hippocampal neurotrophin genes by antisense DNA to c-fos (Meeting abstract). Proc Annu Meet Am Assoc Cancer Res 1995; 36: A2453
263. Hisanaga K, Kogure K. Possible involvement of c-fos translational regulation in the interaction between glutamate and neurotrophic factors in brain ischemia. Prog Brain Res 1993; 96: 209-219.
264. Uemura Y, Kowall NW, Beal ME Global ischemia induces NMDA receptor-mediated c-fos expression in neurons resistant to injury in gerbil hippocampus. Brain Res 1991; 542(2): 343-347.
265. Neumann-Haefelin T, Wiessner C, Vogel P, Back T, Hossmann KA. Differential expression of the immediate early genes c-fos, c-jun, junB, and NGFI-B in the rat brain following transient forebrain ischemia. J Cereb Blood Flow Metab 1994; 14(2): 206-216.
266. Kiessling M, Stumm G, Xie Y, et al. Differential transcription and translation of immediate early genes in the gerbil hippocampus after transient global ischemia. J Cereb Blood Flow Metab 1993; 13(6): 914-924.
267. Takemoto O, Tomimoto H, Yanagihara T. Induction of c-fos and c-jun gene products and heat shock protein after brief and prolonged cerebral ischemia in gerbils. Stroke 1995; 26(9): 1639-1648.
268. Collaco-Moraes Y, Aspey BS, de Belleroche JS, Harrison MJ. Focal ischemia causes an extensive induction of immediate early genes that are sensitive to MK-801. Stroke 1994; 25(9): 1855-1860; discussion 1861.
269. Dragunow M, Beilharz E, Sirimanne E, et al. Immediateearly gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxicischaemic injury to the young rat brain. Brain Res Mol Brain Res 1994; 25(1-2): 19-33.
270. Gillardon F, Lenz C, Waschke KF, et al. Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res 1996; 40(2): 254-260.
271. Kiessling M, Gass P. Stimulus-transcription coupling in focal cerebral ischemia. Brain Pathol 1994; 4(1): 77-83.
272. Soriano MA, Ferrer I, Rodriguez-Farre E, Planas AM. Apoptosis and c-Jun in the thalamus of the rat following cortical infarction. Neuroreport 1996; 7(2): 425-428.
273. Salminen A, Liu PK, Hsu CY. Alteration of transcription factor binding activities in the ischemic rat brain. Biochem Biophys Res Commun 1995; 212(3): 939-944.
274. Estus S, Zaks WJ, Freeman RS, Gruda M, Bravo R, Johnson EM. Altered gene expression in neurons during programmed cell death; identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 1994; 127: 1117-1727.
275. Liu PK, Salminen A, He YY, et al. Suppression of ischemia-induced fos expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA [see comments]. Ann Neurol 1994; 36(4): 566-576.
276. Sharp FR, Kinouchi H, Koistinaho J, Chan PH, Sagar SM. HSP70 heat shock gene regulation during ischemia. Stroke 1993; 24(12 Suppl): 172-5.
277. Massa SM, Swanson RA, Sharp FR. The stress gene reponse in brain. Cerebrovasc Brain Metab Rev 1996; 8: 95-158.
278. Vass K, Welch WJ, Nowak TS, Jr. Localisation of 70 kDa stress protein induction in gerbil brain after ischemia. Acta Neuropathol (Berl) 1988; 77: 128-135.
279. Nowak TS, Jr., IkedaJ, Nakajima T. 70-kDa heat shock protein and c-fos gene expression after transient ischemia. Stroke 1990; 21(11 Suppl): III107-11.
280. Kato H, Liu XH, Nakata N, Kogure K. Immunohistochemical visualisation of the heat shock protein-70 in the gerbil hippocampus following repeated brief cerebral ischemia. Brain Res 1993; 615: 240-244.
281. Kirino T, Tsujita Y, Tamura A. Induced tolerance to ischaemia in gerbil hippocampal neurons J Cereb Blood Flow Metab 1991; 11: 299-307.
282. Chopp M, Li Y, Dereski MO, Levine SR, Yoshida Y, Garcia JH. Neuronal injury and expression of 72-kDa heat-shock protein after forebrain ischemia in the rat. Acta Neuropathol (Berl) 1991; 83(1): 66-71.
283. Simon RP, Cho H, Gwinn R, Lowenstein DH. The temporal profile of 72-kDa heat shock protein expression following global ischemia. J Neurosci 1991; 11:881-889.
284. Nowak TS, Jr., Jacewicz M. The heat shock/stress response in focal cerebral ischemia. Brain Pathol 1994; 4(1): 67-76.
285. Li Y Chopp M, Garcia JH, Yoshida Y, Zhang ZG, Levine SR. Distribution of the 72-kd heat-shock protein as a function of transient focal cerebral ischemia in rats. Stroke 1992; 23(9): 1292-1298.
286. Li Y, Chopp M, Zhang ZG, Zhang RL, Garcia JH. Neuronal survival is associated with 72-kDa heat shock protein expression after transient middle cerebral artery occlusion in the rat. J Neurol Sci 1993; 120(2): 187-194.